1. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice;Agrawal;Proc. Natl. Acad. Sci. USA,1991
2. Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5′ cap region;Bacon;Oncogene Res.,1991
3. Phase I trial of an antisense oligonucleotide OL(1) p53 in haematologic malignancies;Bishop;J. Clin. Oncol.,1996
4. Antisense strategies in the treatment of leukemias;Calabretta;Semin. Oncol.,1996
5. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model;Cotter;Oncogene,1994